Trials / Completed
CompletedNCT01607190
Biomarkers of Diabetic Retinopathy Progression
Biomarkers of Diabetic Retinopathy Progression.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Association for Innovation and Biomedical Research on Light and Image · Academic / Other
- Sex
- All
- Age
- 35 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to validate a predictive model of diabetic retinopathy progression in patients with diabetes mellitus type 2 patients to clinically significant macular edema (CSME) needing treatment either photocoagulation or intravitreal injections (ITV) using non-invasive techniques.
Conditions
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2016-04-01
- Completion
- 2017-12-01
- First posted
- 2012-05-30
- Last updated
- 2018-07-19
Locations
2 sites across 2 countries: India, Portugal
Source: ClinicalTrials.gov record NCT01607190. Inclusion in this directory is not an endorsement.